Literature DB >> 16108845

The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population-based screening study.

A Sandbaek1, T Lauritzen, K Borch-Johnsen, K Mai, J S Christiansen.   

Abstract

AIM: To evaluate the degree of concordance between venous plasma glucose (PG) and capillary whole blood glucose (BG) in diagnosing Type 2 diabetes and to compare the prevalence of confirmed and unconfirmed Type 2 diabetes.
METHODS: All 40- to 69-year olds without known diabetes listed with five general practices were invited for screening (2051 persons). People identified by screening as being at high risk for having diabetes (random BG (rBG) > or = 4.5 mmol/l or HbA1c > or = 5.9%) were examined using BG and PG. The main outcome measures were confirmed diabetes cases (one diabetic glucose value plus symptoms or two diabetic glucose values on two different days) and unconfirmed diabetes (one diabetic glucose value on the first day of testing).
RESULTS: One thousand and twenty-eight (50%) accepted screening. Diabetes was confirmed by BG or PG in 22 patients (1.8%), and in 14 of these by both BG and PG. Four patients in whom diabetes was confirmed only by BG had unconfirmed diabetes by PG. Three of four people in whom diabetes was confirmed only by PG had unconfirmed diabetes according to BG. The prevalence of unconfirmed diabetes was 3.3% and the prevalence of confirmed diabetes 2.1%.
CONCLUSION: Confirmed diabetes can be diagnosed by either BG or PG. BG seems more convenient than PG for use in general practice. The prevalence of confirmed diabetes was lower than the prevalence of unconfirmed diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16108845     DOI: 10.1111/j.1464-5491.2005.01491.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India--the Chennai Urban Rural Epidemiology Study (CURES-17).

Authors:  V Mohan; M Deepa; R Deepa; C S Shanthirani; S Farooq; A Ganesan; M Datta
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

2.  HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark.

Authors:  T Lauritzen; A Sandbaek; M V Skriver; K Borch-Johnsen
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

3.  Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark.

Authors:  S S Rasmussen; C Glümer; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

4.  HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark.

Authors:  M V Skriver; K Borch-Johnsen; T Lauritzen; A Sandbaek
Journal:  Diabetologia       Date:  2010-08-11       Impact factor: 10.122

5.  General effect on high-risk persons when general practitioners are trained in intensive treatment of type 2 diabetes.

Authors:  Signe S Rasmussen; Charlotte Glümer; Annelli Sandbaek; Torsten Lauritzen; Knut Borch-Johnsen
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

6.  A combined analysis of 48 type 2 diabetes genetic risk variants shows no discriminative value to predict time to first prescription of a glucose lowering drug in Danish patients with screen detected type 2 diabetes.

Authors:  Malene Hornbak; Kristine Højgaard Allin; Majken Linnemann Jensen; Cathrine Juel Lau; Daniel Witte; Marit Eika Jørgensen; Annelli Sandbæk; Torsten Lauritzen; Åsa Andersson; Oluf Pedersen; Torben Hansen
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

7.  Prevalence of prediabetes and type 2 diabetes in two non-random populations aged 44-77 years in the Faroe Islands.

Authors:  Anna Sofía Veyhe; Jens Andreassen; Jónrit Halling; Philippe Grandjean; Maria Skaalum Petersen; Pál Weihe
Journal:  J Clin Transl Endocrinol       Date:  2019-03-20

8.  Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study.

Authors:  A Sandbaek; S J Griffin; G Rutten; M Davies; R Stolk; K Khunti; K Borch-Johnsen; N J Wareham; T Lauritzen
Journal:  Diabetologia       Date:  2008-04-29       Impact factor: 10.122

Review 9.  Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes.

Authors:  Kamlesh Khunti; Hamidreza Mani; Felix Achana; Nicola Cooper; Laura J Gray; Melanie J Davies
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

10.  A home-based method for the detection of impaired glucose tolerance in hypertensive primary care patients.

Authors:  Lukas Zandén; Håkan Bergh
Journal:  Scand J Prim Health Care       Date:  2014-04-29       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.